Development of Echinocandin Resistance in Clavispora lusitaniae during Caspofungin TreatmentDESNOS-OLLIVIER, Marie; MOQUET, Olivier; CHOUAKI, Taieb et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 6, pp 2304-2306, issn 0095-1137, 3 p.Article

Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use studyKARTSONIS, Nicholas A; SAAH, Alfred; LIPKA, C. Joy et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 5, pp 878-881, issn 0305-7453, 4 p.Article

Retrospective study of the safety of caspofungin in immunocompromised pediatric patientsFRANKLIN, Jeremy A; MCCORMICK, John; FLYNN, Patricia M et al.The Pediatric infectious disease journal. 2003, Vol 22, Num 8, pp 747-749, issn 0891-3668, 3 p.Article

Caspofungin Etest Endpoint for Aspergillus Isolates Shows Poor Agreement with the Reference Minimum Effective ConcentrationFULLER, Jeff; SCHOFIELD, Adam; JIWA, Safeer et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 2, pp 479-482, issn 0095-1137, 4 p.Article

Assessment of the paradoxical effect of caspofungin in therapy of candidiasisCLEMENS, Karl V; ESPIRITU, Marife; PARMAR, Rachana et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1293-1297, issn 0066-4804, 5 p.Article

Caspofungin Affects Growth of Paracoccidioides brasiliensis in Both Morphological PhasesRODRIGUEZ-BRITO, Sabrina; NINO-VEGA, Gustavo; SAN-BLAS, Gioconda et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5391-5394, issn 0066-4804, 4 p.Article

Breakthrough invasive mould infections in patients treated with caspofunginPHAI PANG, Katy-Anna; GODET, Cendrine; DATRY, Annick et al.The Journal of infection. 2012, Vol 64, Num 4, pp 424-429, issn 0163-4453, 6 p.Article

Caspofungin Disk Diffusion Breakpoints and Quality ControlBROWN, Steven D; TRACZEWSKI, Maria M.Journal of clinical microbiology (Print). 2008, Vol 46, Num 6, pp 1927-1929, issn 0095-1137, 3 p.Article

Flow cytometry susceptibility testing for the antifungal caspofunginMITCHELL, M; HUDSPETH, M; WRIGHT, A et al.Journal of clinical microbiology (Print). 2005, Vol 43, Num 6, pp 2586-2589, issn 0095-1137, 4 p.Article

Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescentsWALSH, Thomas J; ADAMSON, Peter C; MILLER, Alisha et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4536-4545, issn 0066-4804, 10 p.Article

Les échinocandines : Une nouvelle classe thérapeutique antifongique, un nouveau mécanisme d'action = Echinocandins: a new class of antifungal agents, a new mechanism of actionDATRY, A; THELLIER, M.Journal de mycologie médicale. Supplément. 2002, Vol 12, pp 1S5-1S9, issn 1166-7680Article

Breakthrough Hormographiella aspergillata Infections Arising in Neutropenic Patients Treated Empirically with CaspofunginSUAREZ, Felipe; OLIVIER, Gaelle; GARCIA-HERMOSO, Dea et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 1, pp 461-465, issn 0095-1137, 5 p.Article

Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofunginELEONORA MILICI, Maria; MASSIMO MAIDA, Carmelo; SPREGHINI, Elisabetta et al.Journal of clinical microbiology (Print). 2007, Vol 45, Num 11, pp 3529-3533, issn 0095-1137, 5 p.Article

Hepatic uptake of the novel antifungal agent caspofunginSANDHU, Punam; LEE, Wooin; XIN XU et al.Drug metabolism and disposition. 2005, Vol 33, Num 5, pp 676-682, issn 0090-9556, 7 p.Article

Profiling the Aspergillus fumigatus Proteome in Response to CaspofunginCAGAS, Steven E; RAJA JAIN, Mohit; HONG LI et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 1, pp 146-154, issn 0066-4804, 9 p.Article

The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to AspergillusAYCICEK, Abdullah; CETINKAYA, Zafer; KIYICI, Halil et al.European archives of oto-rhino-laryngology. 2009, Vol 266, Num 11, pp 1703-1709, issn 0937-4477, 7 p.Article

Prise en charge des candidoses et aspergilloses invasives. Actualités sur la caspofungineLa Lettre de l'infectiologue. 2008, Num MARS, issn 0296-9009, 7 p., HSSerial Issue

Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeysSANDHU, Punam; XIN XU; BONDISKEY, Peter J et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1272-1280, issn 0066-4804, 9 p.Article

Caspofungin activity against clinical isolates of fluconazole-resistant CandidaPFALLER, Michael A; MESSER, Shawn A; BOYKEN, Linda et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 12, pp 5729-5731, issn 0095-1137, 3 p.Article

Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infectionANTTILA, Veli-Jukka; PIILONEN, Anneli; VALTONEN, Matti et al.Scandinavian journal of infectious diseases. 2003, Vol 35, Num 11-12, pp 893-894, issn 0036-5548, 2 p.Article

Aspergilloses invasives/aspects thérapeutiques : Caspofungine = Invasive aspergillosis/therapeutic aspects: caspofunginCAILLOT, D.Journal de mycologie médicale. Supplément. 2002, Vol 12, pp 1S18-1S19, issn 1166-7680Article

Nouveaux antifongiques systémiques = New antifungalsCAZENAVE, B; LANTERNIER, F; LORTHOLARY, O et al.La Lettre de l'infectiologue. 2010, Vol 25, Num 5, pp 178-184, issn 0296-9009, 7 p.Article

Paradoxical effect of caspofungin: Reduced activity against Candida albicans at high drug concentrationsSTEVENS, David A; ESPIRITU, Marife; PARMAR, Rachana et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 9, pp 3407-3411, issn 0066-4804, 5 p.Article

The echinocandins, first novel class of antifungals in two decades: Will they live up to their promise?GRAYBILL, J R.International journal of clinical practice (Esher). 2001, Vol 55, Num 9, pp 633-638, issn 1368-5031Article

Page / 20